|

Efficacy of Nitrous Oxide in OCD: Pilot Study

RECRUITINGPhase 2Sponsored by Stanford University
Actively Recruiting
PhasePhase 2
SponsorStanford University
Started2021-04-17
Est. completion2026-09
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03826693

Summary

This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18-65
* Primary diagnosis of OCD
* Sufficient severity of OCD symptoms
* Ability to tolerate a treatment-free period
* Capacity to provide informed consent

Exclusion Criteria:

* Psychiatric or medical conditions that make participation unsafe
* Pregnant or nursing females
* Concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)

Conditions2

AnxietyObsessive-compulsive Disorder

Locations1 site

Stanford University
Stanford, California, 94304
Pavithra Makunda, MS650-723-4095ocdresearch@stanford.edu

Browse More Trials

Anxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.